GleamWall
中文EN

LFCR LIFECORE BIOMEDICAL, INC. \DE\

Pharmaceutical Preparations · Nasdaq · SEC CIK 1005286 · Fiscal year ends 05/25

Financial factors as of 2025-05-25 (2025Q4), TTM = sum of the last four quarters

Growth

TTM revenue YoY0.5%
TTM net income YoY-422.3%
TTM EPS YoY-484.8%
Revenue 3-yr CAGR5.0%
Net income 3-yr CAGR—

Margins

Gross margin31.3%
Operating margin-13.4%
Net margin-30.0%
FCF margin-10.6%
EBITDA margin-7.2%

Returns

ROE-612.1%
ROA-15.7%
ROIC (approx.)-10.7%
Asset turnover0.52x

Leverage & solvency

Liabilities / assets80.2%
Debt / equity100.20x
Current ratio2.84x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.00x
Accruals ratio-15.6%
Payout ratio—
Capex / revenue10.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-05-25FY20242024-05-26
Income statement
Revenue$128.87M$128.26M
Cost of revenue$88.57M$86.41M
Gross profit$40.30M$41.85M
R&D expense$8.26M$8.57M
SG&A expense$44.05M$40.46M
Operating income-$17.25M-$8.84M
Interest expense$22.17M$18.15M
Pretax income-$38.67M$9.51M
Income tax$43,000$183,000
Net income-$38.72M$12.01M
EBITDA-$9.22M-$890,000
EPS (basic)-1.270.39
EPS (diluted)-1.270.33
Weighted avg. shares (diluted)34.82M36.66M
Balance sheet
Cash & equivalents$8.27M$8.46M
Receivables—$31.15M
Inventory$32.29M$39.98M
Current assets$85.68M$81.03M
PP&E, net$129.01M$149.16M
Goodwill$13.88M$13.88M
Intangibles$4.20M$4.20M
Total assets$239.34M$253.96M
Current liabilities$30.18M$38.87M
Short-term debt$3.44M$943,000
Long-term debt$130.44M$124.67M
Total debt$133.87M$125.61M
Total liabilities$191.91M$200.06M
Shareholders' equity$1.34M$11.31M
Net debt$125.61M$117.15M
Shares outstanding37.03M30.56M
Cash flow statement
Operating cash flow-$206,000$257,000
Capital expenditure$13.41M$18.39M
Free cash flow-$13.62M-$18.14M
Investing cash flow-$6.42M-$18.39M
Financing cash flow$6.42M$7.51M
Depreciation & amortization$8.03M$7.95M
Stock-based compensation$10.16M$6.20M

Free plan shows the latest 2 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.